Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine C Allen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Addiction Medicine|August 16, 2022
Feasibility of Emergency Department-based Fentanyl Test Strip DistributionRafael A Lima, Lydia B Karch, Patrick M Lank, et al.
Journal of the American Pharmacists Association : Japha|July 22, 2020
Development of a take-home naloxone program at an urban academic emergency departmentVidya Eswaran, Katherine C Allen, Daniel S Cruz, et al.
Drug Safety|January 9, 2015
Risk of anaphylaxis with repeated courses of rasburicase: a Research on Adverse Drug Events and Reports (RADAR) projectKatherine C Allen, Amanda H Champlain, Jonathan A Cotliar, et al.
Joint Commission Journal on Quality and Patient Safety|September 7, 2019
A Quality Improvement Initiative Featuring Peer-Comparison Prescribing Feedback Reduces Emergency Department Opioid PrescribingJonathan W Andereck, Quentin R Reuter, Katherine C Allen, et al.
Annals of Emergency Medicine|April 4, 2020
Take-Home Naloxone Program Implementation: Lessons Learned From Seven Chicago-Area HospitalsVidya Eswaran, Katherine C Allen, Diana C Bottari, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
NAD <sup>+</sup> activates renal metabolism and protects from chronic kidney disease in a model of Alport syndromeBryce A Jones, Debora L Gisch, Komuraiah Myakala, et al.
JCI Insight|March 10, 2025
NAD+ prevents chronic kidney disease by activating renal tubular metabolismBryce A Jones, Debora L Gisch, Komuraiah Myakala, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Addiction Medicine|August 16, 2022
Feasibility of Emergency Department-based Fentanyl Test Strip DistributionRafael A Lima, Lydia B Karch, Patrick M Lank, et al.
Journal of the American Pharmacists Association : Japha|July 22, 2020
Development of a take-home naloxone program at an urban academic emergency departmentVidya Eswaran, Katherine C Allen, Daniel S Cruz, et al.
Drug Safety|January 9, 2015
Risk of anaphylaxis with repeated courses of rasburicase: a Research on Adverse Drug Events and Reports (RADAR) projectKatherine C Allen, Amanda H Champlain, Jonathan A Cotliar, et al.
Joint Commission Journal on Quality and Patient Safety|September 7, 2019
A Quality Improvement Initiative Featuring Peer-Comparison Prescribing Feedback Reduces Emergency Department Opioid PrescribingJonathan W Andereck, Quentin R Reuter, Katherine C Allen, et al.
Annals of Emergency Medicine|April 4, 2020
Take-Home Naloxone Program Implementation: Lessons Learned From Seven Chicago-Area HospitalsVidya Eswaran, Katherine C Allen, Diana C Bottari, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
NAD <sup>+</sup> activates renal metabolism and protects from chronic kidney disease in a model of Alport syndromeBryce A Jones, Debora L Gisch, Komuraiah Myakala, et al.
JCI Insight|March 10, 2025
NAD+ prevents chronic kidney disease by activating renal tubular metabolismBryce A Jones, Debora L Gisch, Komuraiah Myakala, et al.
Pageof 1